BSPM [Biostar Pharmaceuticals,] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China, 712046 011-86-29-33686638 (Address, including zip code, and telephone number, Ronghua Wang Chief Executive Officer] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 dated December 18, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 5 ex23-2.htm EX-23.2]

By | 2016-03-03T10:30:45+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China, 712046 011-86-29-33686638 (Address, including zip code, and telephone number, Ronghua Wang Chief Executive Officer] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 dated December 18, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 5 ex23-2.htm EX-23.2]

By | 2016-03-03T10:32:16+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

EVK [Ever-Glory International,] 8-K: FORM 8-K CURRENT REPORTte of report (Date of

[FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): December 18, 2013 (December 12, 2013) EVER-GLORY INTERNATIONAL, Florida 000-28806 65-0420146 (State or other jurisdiction oforporation) (Commission File No.) (IRS Employer Identification No.) Ever-Glorymmercial Center, 509 Chengxin Road,Jiangning Development Zone, Nanjing,Jiangsu Province, Peoples Republic of China]

MPEL [Melco Crown Entertainment] 6-K: Melco Crown (Philippines) Resorts Corporation Announces Pricing of

[Melco Crown (Philippines) Resorts Corporation Announces Pricing of Senior Notes Offering of MCE Leisure (Philippines) Corporation December 19, 2013 MCP Melco Crown Philippines MCE Melco Crown Entertainment MCE Leisure Philippines Notes The Notes offering consists of PHP 15 billion (equivalent to approximately US$340 million as of the date of this release) aggregate principal amount of 5.00% senior notes due 2019.]

By | 2016-03-06T16:22:48+00:00 December 19th, 2013|Categories: Chinese Stocks, MPEL, Webplus ver|Tags: , , , , , |0 Comments

VIMC [Vimicro International] SC 13D/A: (Original Filing)

[PURCHASE AND SALE AGREEMENT Agreement Company Schedule 1 Seller Sellers Schedule 1.01(c) Ordinary Shares Schedule 1.01(c) ADSs Securities SECTION I PURCHASE AND SALE OF SECURITIES Sale of Securities 1.01 Schedule 1.01(a) First Tranche Ordinary Shares Schedule 1.01(a) First Tranche ADSs Schedule 1.01(b) Second Tranche Ordinary Shares Schedule 1.01(b) Second Tranche ADSs Purchase Price 1.02 Schedule 1.01(a) Schedule 1.01(b) Ordinary Share] [SCHEDULE 13D (AMENDMENT NO. 3) VIMICRO INTERNATIONAL CORPORATION (Name of Issuer) ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 92718N109** (CUSIP Number) THOMAS J. MURPHY C/O GENERAL ATLANTIC SERVICE COMPANY, LLC 55 East 52nd Street, 32nd Floor New York, NY 10055 (212) 715-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]

By | 2016-03-31T17:51:40+00:00 December 19th, 2013|Categories: Chinese Stocks, SEC Original, VIMC|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046 011-86-29-33686638 (Address,luding zipde, and telephone number,] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.1 ex23-1.htm 4 EX-23.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 ex23-2.htm 5 EX-23.2]

By | 2016-02-07T15:00:18+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] CORRESP: (Original Filing)

[December 19, 2013 VIA EDGAR Attention: Kevin L. Vaughn, Accounting Branch Chief Martin James, Senior Assistant Chief Accountant Eric Atallah, Staff Accountant Re: Semiconductor Manufacturing International Corporation Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 15, 2013 File No. 001-31994 Ladies and Gentlemen: Company Staff Commission Comment Letter Semiconductor Manufacturing International Corporation (the “ Form 20-F]

By | 2016-03-08T14:03:04+00:00 December 19th, 2013|Categories: Chinese Stocks, SEC Original, SMI|Tags: , , , , , |0 Comments

VIMC [Vimicro International] SC 13D/A: PURCHASE AND SALE AGREEMENT Agreement Company Schedule 1

[PURCHASE AND SALE AGREEMENT Agreement Company Schedule 1 Seller Sellers Schedule 1.01(c) Ordinary Shares Schedule 1.01(c) ADSs Securities SECTION I PURCHASE AND SALE OF SECURITIES Sale of Securities 1.01 Schedule 1.01(a) First Tranche Ordinary Shares Schedule 1.01(a) First Tranche ADSs Schedule 1.01(b) Second Tranche Ordinary Shares Schedule 1.01(b) Second Tranche ADSs Purchase Price 1.02 Schedule 1.01(a) Schedule 1.01(b) Ordinary Share] [SCHEDULE 13D (AMENDMENT NO. 3) VIMICRO INTERNATIONAL CORPORATION (Name of Issuer) ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 92718N109** (CUSIP Number) THOMAS J. MURPHY C/O GENERAL ATLANTIC SERVICE COMPANY, LLC 55 East 52nd Street, 32nd Floor New York, NY 10055 (212) 715-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]

By | 2016-03-31T17:53:02+00:00 December 19th, 2013|Categories: Chinese Stocks, VIMC, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046 011-86-29-33686638 (Address,luding zipde, and telephone number,] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.1 ex23-1.htm 4 EX-23.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 ex23-2.htm 5 EX-23.2]

By | 2016-02-07T15:00:53+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] CORRESP: December 19, 2013 VIA EDGAR Attention: Kevin L.

[December 19, 2013 VIA EDGAR Attention: Kevin L. Vaughn, Accounting Branch Chief Martin James, Senior Assistant Chief Accountant Eric Atallah, Staff Accountant Re: Semiconductor Manufacturing International Corporation Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 15, 2013 File No. 001-31994 Ladies and Gentlemen: Company Staff Commission Comment Letter Semiconductor Manufacturing International Corporation (the “ Form 20-F]

By | 2016-03-08T14:04:12+00:00 December 19th, 2013|Categories: Chinese Stocks, SMI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar